Oskar Eriksson
Associate professor at Institutionen för immunologi, genetik och patologi; Forskningsprogram: Vaskulärbiologi; Forskargrupp Bo Nilsson
- E-mail:
- oskar.eriksson@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
More information is available to staff who log in.
Short presentation
MD, PhD
Resident physician in clinical immunology and transfusion medicine
Associate professor (docent) in experimental clinical immunology
Biography
2013 MD Uppsala University
2015 PhD Uppsala University
2016-2018 Post doc financed by Swedish Research Coucil, Harvard Medical School, Boston, USA
2019-2022 Internship, Uppsala University Hospital
2022- Resident physician in clinical immunology and transfusion medicine, Uppsala University Hospital
2022 Associate professor (docent) in experimental clinical immunology
Publications
Recent publications
- A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile (2024)
- Combined Heterozygous Genetic Variations in Complement C2 and C8B (2023)
- Complement and platelets (2023)
- How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system (2023)
- Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19 (2022)
All publications
Articles
- A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile (2024)
- Combined Heterozygous Genetic Variations in Complement C2 and C8B (2023)
- Complement and platelets (2023)
- How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system (2023)
- Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19 (2022)
- Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis-A Swedish biobank study (2022)
- Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients. (2022)
- How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment (2022)
- The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System (2021)
- Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients (2020)
- Blood type A associates with critical COVID-19 and death in a Swedish cohort (2020)
- The Human Platelet as an Innate Immune Cell (2019)
- Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics (2019)
- First-in-class PET tracer for the glucagon receptor (2017)
- A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression (2016)
- Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer (2016)
- Tissue Factor Noncoagulant Signaling (2015)
- Neutrophil CD64 expression - comparison of two different flow cytometry protocols on EPICs MCL and the Leuko64 (TM) assay on a Celldyn Sapphire haematology analyser (2015)
- Cross-talk between tissue factor and EPHA2 in cancer (2015)
- The Eph Tyrosine Kinase Receptors EphB2 and EphA2 Are Novel Proteolytic Substrates of Tissue Factor/Coagulation Factor VIIa (2014)
- Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor (2014)
- The insulin-like growth factor 1 receptor mediates tissue factor/FVIIa-induced cell survival (2013)
Books
